Anzeige
Mehr »
Donnerstag, 18.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QE44 | ISIN: US45175B1098 | Ticker-Symbol:
NASDAQ
15.09.25 | 22:00
3,030 US-Dollar
0,00 % 0,000
Branche
Dienstleistungen
Aktienmarkt
ASIEN
1-Jahres-Chart
IHUMAN INC ADR Chart 1 Jahr
5-Tage-Chart
IHUMAN INC ADR 5-Tage-Chart
PR Newswire
33 Leser
Artikel bewerten:
(0)

iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results

BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the second quarter ended June 30, 2025.

Second Quarter 2025 Highlights

  • Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year.
  • Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year.
  • Operating income was RMB19.5 million (US$2.7 million), compared with RMB18.8 million in the same period last year.
  • Net income was RMB31.9 million (US$4.5 million), compared with RMB24.7 million in the same period last year.
  • Average total MAUs[1] for the second quarter were 23.72 million, compared with 24.57 million in the same period last year.

[1] "Average total MAUs" refers to the monthly average of the sum of the MAUs of each of the Company's apps during a specific period, which is counted based on the number of unique mobile devices through which such app is accessed at least once in a given month, and duplicate access to different apps is not eliminated from the total MAUs calculation.

Dr. Peng Dai, Director and Chief Executive Officer of iHuman, commented, "During the second quarter, we continued to advance our product roadmap and expand our international presence with several key updates. Our flagship app, iHuman Chinese-long recognized as an industry benchmark-introduced new features to make character exploration more intuitive and engaging. One specific highlight is the new photo recognition function that covers most daily-use Chinese characters. Children can simply take a picture of an unfamiliar character, and the app will instantly display its meaning, related words, example sentences, and cultural context, seamlessly turning everyday curiosity into a learning opportunity. We also launched a speaking feature that uses intelligent voice analysis to provide real-time feedback on pronunciation, helping children build confidence and fluency in verbal expression through practice.

Internationally, we launched a major upgrade to Aha Makeover, transforming it from a traditional styling experience into a vibrant, story-driven world. The update introduces missions, a tiered rewards system, and an expansive world map with different themed zones. The update also features a new virtual girl group of five original characters, each with a distinctive style and personality. Users can interact with them through various creative activities, such as experimenting with hairstyles, applying makeup, mixing and matching outfits, and personalizing rooms in a cozy virtual home. These interactions unlock rewards and advance the storyline, sparking users' creativity through diverse challenges. By combining character-led narratives with creative styling tools and engaging missions, the update delivers a distinctive and immersive experience that strengthens user engagement over time.

We also took a major step forward in our global content strategy by establishing a strategic partnership with Cricket Media, a highly respected children's brand with more than five decades of experience and strong ties to schools, libraries, and households across the U.S. By leveraging Cricket Media's award-winning library- spanning genres like science, art, history, poetry, comics, and fiction -and our proven expertise in content digitization, edutainment, and interactive learning design, we are reimaging these classic resources for the digital age. Recently, we jointly launched Reading Stars, an intuitive app that retains the depth of traditional reading while offering interactive activities, motivating rewards, and personalized pathways to create a richer experience for young readers. This partnership not only introduces a compelling new reading product, but also deepens our presence in the U.S. education and consumer markets, bolsters our brand recognition abroad, and provides an effective platform for building long-term distribution channels and localized product offerings.

Building on our strength in digital products, we are also expanding our entertainment content through our animation studio, Kunpeng. Our flagship Cosmicrew franchise, which first aired in 2018, remains a long-standing favorite among children and one of the most recognized and beloved names in its category. This summer, Cosmicrew continued its strong performance across major streaming platforms, underscoring its enduring popularity. Within the franchise, the Super Mecha Dinosaurs subseries has also built a devoted fanbase. In May, we released a new season that quickly attracted broad viewership on leading streaming platforms, further expanding the series' strong following. Importantly, as an integral part of iHuman's ecosystem, Kunpeng's original IPs not only broaden our entertainment lineup but also further increase the visibility of our overall IP portfolio within iHuman apps. This strengthens user engagement, creating a self-reinforcing flywheel where education and entertainment are closely integrated and amplify each other over time.

By continuing to innovate, expanding our global footprint, and growing our entertainment portfolio, we are strengthening the foundation for long-term growth and creating more opportunities to engage audiences worldwide."

Ms. Vivien Weiwei Wang, Director and Chief Financial Officer of iHuman, added, "We are pleased to deliver another solid quarter of results, marking our 14th consecutive quarter of profitability. This achievement is a testament to our disciplined execution and firm commitment to sustainable development. This quarter, we continued to strengthen our product portfolio and expand collaboration with ecosystem partners, creating new synergies and opportunities that lay a strong foundation for long-term growth. We are also actively expanding the role of AI across our operations, applying it not only to enrich user experiences but also to reimagine our operational processes. From automating routine tasks and streamlining workflows to enhancing data-driven insights, AI is enabling us to respond faster, operate more precisely, and capture greater efficiencies across the board.

Backed by an industry-leading product lineup, a healthy balance sheet, and an agile operating model, we are well positioned to capitalize on new opportunities, scale globally, and continue creating value for our shareholders."

Second Quarter 2025 Unaudited Financial Results

Revenues

Revenues were RMB200.2 million (US$27.9 million), compared with RMB215.1 million in the same period last year. The decrease in revenues was primarily due to the decline in China's newborn population and more conservative consumer spending.

Average total MAUs for the quarter were 23.72 million, compared with 24.57 million in the same period last year.

Cost of Revenues

Cost of revenues was RMB64.4 million (US$9.0 million), compared with RMB63.4 million in the same period last year.

Gross Profit and Gross Margin

Gross profit was RMB135.7 million (US$19.0 million), compared with RMB151.7 million in the same period last year. Gross margin was 67.8%, compared with 70.5% in the same period last year. The decrease in gross margin was mainly due to the diversification and structural upgrades of the Company's product portfolio.

Operating Expenses

Total operating expenses were RMB116.3 million (US$16.2 million), a decrease of 12.5% from RMB132.9 million in the same period last year.

Research and development expenses were RMB52.8 million (US$7.4 million), a decrease of 7.7% from RMB57.2 million in the same period last year, primarily due to savings in payroll-related and outsourcing expenses.

Sales and marketing expenses were RMB41.3 million (US$5.8 million), a decrease of 19.5% from RMB51.3 million in the same period last year, primarily due to cost savings in marketing activities.

General and administrative expenses were RMB22.1 million (US$3.1 million), a decrease of 9.3% from RMB24.4 million in the same period last year, primarily due to savings in payroll-related expenses as well as other administrative expenses.

Operating Income

Operating income was RMB19.5 million (US$2.7 million), compared with RMB18.8 million in the same period last year.

Net Income

Net income was RMB31.9 million (US$4.5 million), compared with RMB24.7 million in the same period last year.

Basic and diluted net income per ADS were RMB0.62 (US$0.09) and RMB0.60 (US$0.08), respectively, compared with RMB0.47 and RMB0.45 in the same period last year. Each ADS represents five Class A ordinary shares of the Company.

Deferred Revenue and Customer Advances

Deferred revenue and customer advances were RMB240.0 million (US$33.5 million) as of June 30, 2025, compared with RMB283.3 million as of December 31, 2024.

Cash, Cash Equivalents and Short-term Investments

Cash, cash equivalents and short-term investments were RMB1,100.1 million (US$153.6 million) as of June 30, 2025, compared with RMB1,168.7 million as of December 31, 2024. The decrease was primarily due to the payment of annual bonuses to employees and dividends in the first half of the year.

Exchange Rate Information

The U.S. dollar (US$) amounts disclosed in this press release, except for those transaction amounts that were actually settled in U.S. dollars, are presented solely for the convenience of the reader. The conversion of Renminbi (RMB) into US$ in this press release is based on the exchange rate set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System as of June 30, 2025, which was RMB7.1636 to US$1.00. The percentages stated in this press release are calculated based on the RMB amounts.

Non-GAAP Financial Measures

iHuman considers and uses non-GAAP financial measures, such as adjusted operating income, adjusted net income and adjusted diluted net income per ADS, as supplemental metrics in reviewing and assessing its operating performance and formulating its business plan. The presentation of non-GAAP financial measures is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). iHuman defines adjusted operating income, adjusted net income and adjusted diluted net income per ADS as operating income, net income and diluted net income per ADS excluding share-based compensation expenses, respectively. Adjusted operating income, adjusted net income and adjusted diluted net income per ADS enable iHuman's management to assess its operating results without considering the impact of share-based compensation expenses, which are non-cash charges. iHuman believes that these non-GAAP financial measures provide useful information to investors in understanding and evaluating the Company's current operating performance and prospects in the same manner as management does, if they so choose.

Non-GAAP financial measures are not defined under U.S. GAAP and are not presented in accordance with U.S. GAAP. Non-GAAP financial measures have limitations as analytical tools, which possibly do not reflect all items of expense that affect our operations. Share-based compensation expenses have been and may continue to be incurred in our business and are not reflected in the presentation of the non-GAAP financial measures. In addition, the non-GAAP financial measures iHuman uses may differ from the non-GAAP measures used by other companies, including peer companies, and therefore their comparability may be limited. The presentation of these non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the financial information prepared and presented in accordance with GAAP.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Statements that are not historical facts, including statements about iHuman's beliefs and expectations, are forward-looking statements. Among other things, the description of the management's quotations in this announcement contains forward-looking statements. iHuman may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: iHuman's growth strategies; its future business development, financial condition and results of operations; its ability to continue to attract and retain users, convert non-paying users into paying users and increase the spending of paying users, the trends in, and size of, the market in which iHuman operates; its expectations regarding demand for, and market acceptance of, its products and services; its expectations regarding its relationships with business partners; general economic and business conditions; regulatory environment; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in iHuman's filings with the SEC. All information provided in this press release is as of the date of this press release, and iHuman does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

About iHuman Inc.

iHuman Inc. is a leading provider of tech-powered, intellectual development products in China that is committed to making the child-upbringing experience easier for parents and transforming intellectual development into a fun journey for children. Benefiting from a deep legacy that combines nearly three decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience more efficient. iHuman's unique, fun and interactive product offerings stimulate children's natural curiosity and exploration. The Company's comprehensive suite of innovative and high-quality products include self-directed apps, interactive content and smart devices that cover a broad variety of areas to develop children's abilities in speaking, critical thinking, independent reading and creativity. Leveraging advanced technological capabilities, including 3D engines, AI/AR functionality, and big data analysis on children's behavior & psychology, iHuman believes it will continue to provide superior experience that is efficient and relieving for parents, and effective and fun for children, in China and all over the world, through its integrated suite of tech-powered, intellectual development products.

For more information about iHuman, please visit https://ir.ihuman.com/.

For investor and media enquiries, please contact:

iHuman Inc.
Mr. Justin Zhang
Investor Relations Director
Phone: +86-10-5780-6606
E-mail: [email protected]

Christensen
In China
Ms. Alice Li
Phone: +86-10-5900-1548
E-mail: [email protected]

In the US
Ms. Linda Bergkamp
Phone: +1-480-614-3004
E-mail: [email protected]

iHuman Inc.


UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS


(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

except for number of shares, ADSs, per share and per ADS data)



December 31,


June 30,


June 30,


2024


2025


2025


RMB


RMB


US$







ASSETS






Current assets






Cash and cash equivalents

1,123,292


605,136


84,474

Short-term investments

45,457


495,000


69,099

Accounts receivable, net

52,030


56,318


7,862

Inventories, net

23,475


20,665


2,885

Amounts due from related parties

2,051


1,454


203

Prepayments and other current assets

89,512


85,224


11,897

Total current assets

1,335,817


1,263,797


176,420

Non-current assets






Property and equipment, net

3,476


2,620


366

Intangible assets, net

16,429


14,918


2,082

Operating lease right-of-use assets

14,885


12,310


1,718

Long-term investment

26,333


26,333


3,676

Other non-current assets

22,701


15,110


2,110

Total non-current assets

83,824


71,291


9,952

Total assets

1,419,641


1,335,088


186,372







LIABILITIES






Current liabilities






Accounts payable

30,233


21,204


2,960

Deferred revenue and customer advances

283,251


240,012


33,504

Amounts due to related parties

1,734


1,950


272

Accrued expenses and other current liabilities

126,501


90,252


12,599

Dividend payable

2,164


-


-

Current operating lease liabilities

3,661


2,272


317

Total current liabilities

447,544


355,690


49,652

Non-current liabilities






Non-current operating lease liabilities

11,252


10,006


1,397

Total non-current liabilities

11,252


10,006


1,397

Total liabilities

458,796


365,696


51,049

SHAREHOLDERS' EQUITY






Ordinary shares (par value of US$0.0001 per share,
700,000,000 Class A shares authorized as of
December 31, 2024 and June 30, 2025; 125,122,382
Class A shares issued and 116,084,207 outstanding as
of December 31, 2024; 125,122,382 Class A shares
issued and 112,724,757 outstanding as of June 30,
2025; 200,000,000 Class B shares authorized,
144,000,000 Class B ordinary shares issued and
outstanding as of December 31, 2024 and June 30,
2025; 100,000,000 shares (undesignated) authorized,
nil shares (undesignated) issued and outstanding as of
December 31, 2024 and June 30, 2025)

185


185


26

Additional paid-in capital

996,657


960,173


134,035

Treasury stock

(26,296)


(38,121)


(5,321)

Statutory reserves

8,395


8,395


1,172

Accumulated other comprehensive income

24,009


22,458


3,135

Retained earnings (accumulated deficit)

(42,105)


16,302


2,276

Total shareholders' equity

960,845


969,392


135,323

Total liabilities and shareholders' equity

1,419,641


1,335,088


186,372

iHuman Inc.


UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS


(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

except for number of shares, ADSs, per share and per ADS data)



For the three months ended


For the six months ended


June 30,


March 31,


June 30,


June 30,


June 30,


June 30,


June 30,


2024


2025


2025


2025


2024


2025


2025


RMB


RMB


RMB


US$


RMB


RMB


US$















Revenues

215,107


210,439


200,162


27,942


450,110


410,601


57,318

Cost of revenues

(63,372)


(66,663)


(64,414)


(8,992)


(130,264)


(131,077)


(18,297)















Gross profit

151,735


143,776


135,748


18,950


319,846


279,524


39,021















Operating expenses














Research and development expenses

(57,219)


(55,385)


(52,834)


(7,375)


(125,142)


(108,219)


(15,107)

Sales and marketing expenses

(51,263)


(41,255)


(41,279)


(5,762)


(106,258)


(82,534)


(11,521)

General and administrative expenses

(24,426)


(25,539)


(22,146)


(3,091)


(52,150)


(47,685)


(6,657)

Total operating expenses

(132,908)


(122,179)


(116,259)


(16,228)


(283,550)


(238,438)


(33,285)

Operating income

18,827


21,597


19,489


2,722


36,296


41,086


5,736

Other income, net

9,410


8,000


14,774


2,062


18,420


22,774


3,179

Income before income taxes

28,237


29,597


34,263


4,784


54,716


63,860


8,915

Income tax expenses

(3,574)


(3,079)


(2,374)


(331)


(7,751)


(5,453)


(761)

Net income

24,663


26,518


31,889


4,453


46,965


58,407


8,154















Net income per ADS:














- Basic

0.47


0.51


0.62


0.09


0.89


1.13


0.16

- Diluted

0.45


0.49


0.60


0.08


0.86


1.09


0.15















Weighted average number of ADSs:














- Basic

52,496,541


51,888,345


51,395,308


51,395,308


52,612,845


51,640,464


51,640,464

- Diluted

54,295,419


53,884,134


53,478,410


53,478,410


54,493,509


53,679,910


53,679,910















Total share-based compensation expenses included in:














Cost of revenues

26


8


9


1


66


17


2

Research and development expenses

348


110


67


9


805


177


25

Sales and marketing expenses

45


16


16


2


91


32


4

General and administrative expenses

392


104


(5)


(1)


693


99


14















iHuman Inc.


UNAUDITED RECONCILIATION OF GAAP AND NON-GAAP RESULTS


(Amounts in thousands of Renminbi ("RMB") and U.S. dollars ("US$")

except for number of shares, ADSs, per share and per ADS data)





For the three months ended


For the six months ended


June 30,


March 31,


June 30,


June 30,


June 30,


June 30,


June 30,


2024


2025


2025


2025


2024


2025


2025


RMB


RMB


RMB


US$


RMB


RMB


US$















Operating income

18,827


21,597


19,489


2,722


36,296


41,086


5,736

Share-based compensation expenses

811


238


87


11


1,655


325


45

Adjusted operating income

19,638


21,835


19,576


2,733


37,951


41,411


5,781















Net income

24,663


26,518


31,889


4,453


46,965


58,407


8,154

Share-based compensation expenses

811


238


87


11


1,655


325


45

Adjusted net income

25,474


26,756


31,976


4,464


48,620


58,732


8,199















Diluted net income per ADS

0.45


0.49


0.60


0.08


0.86


1.09


0.15

Impact of non-GAAP adjustments

0.02


0.01


0.00


0.00


0.03


0.00


0.00

Adjusted diluted net income per ADS

0.47


0.50


0.60


0.08


0.89


1.09


0.15















Weighted average number of ADSs - diluted

54,295,419


53,884,134


53,478,410


53,478,410


54,493,509


53,679,910


53,679,910

Weighted average number of ADSs - adjusted

54,295,419


53,884,134


53,478,410


53,478,410


54,493,509


53,679,910


53,679,910

SOURCE iHuman Inc.

© 2025 PR Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.